Factors affecting length of stay according to bronchopulmonary dysplasia severity: a nationwide cohort study in Korea

影响支气管肺发育不良严重程度与住院时间的关系:一项韩国全国性队列研究

阅读:1

Abstract

BACKGROUND: Longer hospitalizations for preterm infants with bronchopulmonary dysplasia (BPD) delay developmental outcomes, increase the risk for hospital-acquired complications, and exert a substantial socioeconomic burden. This study aimed to identify factors associated with an extended length of stay (LOS) at different levels of severity of BPD. METHODS: A cohort study was conducted using the Korean Neonatal Network registry of very low birth weight infants with BPD between 2013 and 2017 through retrospective analysis. RESULTS: A total of 4263 infants were diagnosed with BPD. For mild BPD, infants requiring surgical treatment for patent ductus arteriosus needed a longer LOS [e(adjusted β coefficients (adj β)) 1.041; 95% confidence interval (CI): 0.01-0.08] and hydrocephalus (e(adj β) 1.094; 95% CI 0.01-0.17). In moderate BPD, infants administered steroids or with intraventricular hemorrhage required a longer LOS (e(adj β) 1.041; 95% CI 0.00-0.07 and e(adj β) 1.271; 95% CI 0.11-0.38, respectively). In severe BPD, infants with comorbidities required a longer LOS: pulmonary hypertension (e(adj β) 1.174; 95% CI 0.09-0.23), administrated steroid for BPD (e(adj β) 1.116; 95% CI 0.07-0.14), sepsis (e(adj β) 1.062; 95% CI 0.01-0.11), patent ductus arteriosus requiring surgical ligation (e(adj β) 1.041; 95% CI 0.00-0.08), and intraventricular hemorrhage (e(adj β) 1.016; 95% CI 0.05-0.26). Additionally, the higher the clinical risk index score, the longer the LOS needed for infants in all groups. CONCLUSIONS: The factors affecting LOS differed according to the severity of BPD. Individualized approaches to reducing LOS may be devised using knowledge of the various risk factors affecting LOS by BPD severity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。